AMANDA GEITER: Open Payments
NPI 1699284133 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,249 in 55 payments from 20 companies in 2025. Trend: 2023 $54 · 2024 $1,520 · 2025 $1,249
Food & beverage: $1,077Education: $172
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $309 |
| Incyte Corporation | 5 | $108 |
| GENZYME CORPORATION | 3 | $103 |
| Novartis Pharmaceuticals Corporation | 4 | $93 |
| LEO Pharma Inc. | 5 | $86 |
| SANOFI-AVENTIS U.S. LLC | 1 | $72 |
| Arcutis Biotherapeutics, Inc. | 1 | $69 |
| E.R. Squibb & Sons, L.L.C. | 3 | $59 |
| ABBVIE INC. | 3 | $57 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $48 |
Products named: TREMFYA, DUPIXENT, OPZELURA, COSENTYX, Zoryve, ADBRY, Sotyktu, ILUMYA.
Industry payments across VA — which companies pay providers there.
